Open original FDA record ↗Recall record
- FDA identifier
- Z-2337-2018
- Company in FDA record
- Terumo Medical Corp
- FDA record creation date
- Jun 29, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Two lots of product were released for distribution prior to the completion of all required validation and lot acceptance activities. Although sterile, products from these lots may not function as intended and therefore should not be used.
Source facts
- Action
- On April 9, 2018, the firm sent Urgent Voluntary Medical Device Recall letters and Inventory Confirmation Forms to customers via FedEx. The letter described the product issue. Customers were asked to: 1. Review your Angio-Seal Evolution inventory immediately to identify and isolate affected inventory in order to prevent future use. 2. Your Terumo Territory Manager will visit your facility to confirm product inventory and assist you in completing the enclosed Recall Acknowledgement/ Inventory Confirmation Form. This required documentation, along with the enclosed Fed-Ex product shipment labels will facilitate your return of affected Angio-Seal Evolution product to Terumo Medical Corporation.
- Initiated
- 2018-04-09
- Root cause
- Release of Material/Component prior to receiving test results
- Terminated
- 2019-04-19
- Distribution
- Distributed to accounts in AL, CA, FL, IA, IN, MI, MO, NC, NY, SD, TN, and TX.
- Recall number
- Z-2337-2018
- Recall status
- Terminated
- CDRH record ID
- 164942
- FDA record created
- 2018-06-29
- Recall event number
- 80242